Skip to Main Content

Paper Details

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance.
Cancer Res
76
2015
-resistant cells, FGF receptor, FGF2, FGFR, FGFR3, GIST, GIST cells, Gastrointestinal Stromal Tumor, Gastrointestinal Stromal Tumor Cell, KIT, MAPK, gastrointestinal stromal tumor, imatinib, imatinib-resistant GIST cells, imatinib-resistant cells, oncogenic kinase KIT, patient, patients, sensitive cells, tumor, tumor specimens
Author NameAffiliation
Elie TraerKnight Cancer Institute, Oregon Health and Science University
Jacqueline MartinezKnight Cancer Institute, Oregon Health and Science University
Jennifer DunlapKnight Cancer Institute, Oregon Health and Science University
Christopher L CorlessKnight Cancer Institute, Oregon Health and Science University
Brian P RubinLerner Research Institute, Ohio. Taussig Cancer Center, Cleveland Clinic
Brian P RubinLerner Research Institute, Ohio. Taussig Cancer Center, Cleveland Clinic
Brian J DrukerKnight Cancer Institute, Oregon Health and Science University, Oregon. Howard Hughes Medical Institute
Jeffrey W TynerKnight Cancer Institute, Oregon Health and Science University
  • 1 - 8

Datasets

Release 1.2